Related Experiment Video
Updated: Jun 10, 2025

Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
The role of platelets and megakaryocytes in sepsis and ARDS
Gabriel Leung1, Elizabeth A Middleton1,2
1Division of Pulmonary, Department of Internal Medicine, University of Utah, Salt Lake City, Utah, USA.
Insights
Megakaryocytes and platelets are key players in systemic inflammation during infections like sepsis. Understanding their role in lung injury and organ failure is crucial for developing new treatments for critical illnesses.
Area of Science:
- Immunology
- Hematology
- Pathophysiology
Background:
- Systemic inflammation, including acute respiratory distress syndrome (ARDS) and sepsis, causes significant mortality and morbidity.
- Despite clinical care improvements, severe cases have high mortality rates (∼40%) and persistent morbidity.
- Identifying underlying biological mechanisms and drivers of organ failure is essential for therapeutic development.
Purpose of the Study:
- To review the contribution of megakaryocytes (MKs) and platelets to systemic inflammatory syndromes.
- To explore the role of MKs, including extramedullary MKs, in sepsis pathogenesis.
- To examine alterations in platelet transcriptome and function during sepsis.
Main Methods:
- Literature review focusing on megakaryocytes and platelets in systemic inflammation.
- Analysis of studies on extramedullary MKs during sepsis.
- Examination of research on platelet transcriptome and functional changes in sepsis.
Main Results:
- Megakaryocytes (MKs) and platelets are implicated in the pathogenesis of systemic inflammatory syndromes.
- Extramedullary MKs have been identified during sepsis, highlighting their role beyond the bone marrow.
- Sepsis induces significant alterations in the platelet transcriptome and affects platelet function, including aggregation and heterotypic aggregate formation.
Conclusions:
- Platelets are increasingly recognized as key contributors to inflammation in critical illnesses.
- Further research is necessary to fully elucidate the complex role of platelets in diverse systemic inflammatory syndromes.
- Understanding platelet involvement may reveal novel therapeutic targets for sepsis and ARDS.
Abstract:
Since the global COVID-19 pandemic, there has been a renewed focus on lung injury during infection. Systemic inflammatory responses such as acute respiratory distress syndrome (ARDS) and sepsis are a leading cause of morbidity and mortality for both adults and children. Improvements in clinical care have improved outcomes but mortality remains ∼40% and significant morbidity persists for those patients with severe disease. Mechanistic studies of the underlying biological processes remain essential to identifying therapeutic targets. Furthermore, methods for identifying the underlying drivers of organ failure are key to treating and preventing tissue injury. In this review, we discuss the contribution of megakaryocytes (MKs) and platelets to the pathogenesis of systemic inflammatory syndromes. We explore the role of MKs and the new identification of extramedullary MKs during sepsis. We describe the alterations in the platelet transcriptome during sepsis. Lastly, we explore platelet function as defined by aggregation, activation and the formation of heterotypic aggregates. Much more work is necessary to explore the contribution of platelets to these heterogenous syndromes, but the foundation of platelets as key contributors to inflammation has been laid.
Related Concept Videos
Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Acute Respiratory Failure-I
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Clot Retraction and Fibrinolysis

